ES2056798T3 - Procedimiento para la obtencion de proteinas por tecnologia genetica con utilizacion de celulas hospedantes gram-negativas. - Google Patents

Procedimiento para la obtencion de proteinas por tecnologia genetica con utilizacion de celulas hospedantes gram-negativas.

Info

Publication number
ES2056798T3
ES2056798T3 ES87109492T ES87109492T ES2056798T3 ES 2056798 T3 ES2056798 T3 ES 2056798T3 ES 87109492 T ES87109492 T ES 87109492T ES 87109492 T ES87109492 T ES 87109492T ES 2056798 T3 ES2056798 T3 ES 2056798T3
Authority
ES
Spain
Prior art keywords
gene
proteins
pct
gram
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87109492T
Other languages
English (en)
Inventor
Thomas Ferdinand Dr Meyer
Roman Halter
Johannes Pohlner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Application granted granted Critical
Publication of ES2056798T3 publication Critical patent/ES2056798T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PARA LA OBTENCION DE PROTEINAS POR INGENIERIA GENETICA SE INTRODUCE EN CELULAS HUESPED GRAM NEGATIVAS, UN VECTOR QUE CONTENGA POR LO MENOS UN GEN CODIFICADOR DE LA PROTEINA DESEADA Y EL GEN SE TRANSCRIBE Y SE TRADUCE. PARA LA OBTENCION EXTRACELULAR DE LA PROTEINA SE INCORPORA SU GEN CODIFICADOR EN UN VECTOR, EL GEN PRECURSOR DE IGA-PROTEASA DE MICROORGANISMOS DEL GENERO NEISSERIA, DE MODO QUE EL GEN CODIFICADOR ESTE SITUADO DENTRO DE LA SECUENCIA DEL GEN PRECURSOR DE IGA-PROTEASA. UN PLASMIDO ESPECIALMENTE ADECUADO PARA ELLO ES EL PLASMIDO PLP100 CONTENIDO EN E.COLI DSM 3775.
ES87109492T 1986-07-02 1987-07-01 Procedimiento para la obtencion de proteinas por tecnologia genetica con utilizacion de celulas hospedantes gram-negativas. Expired - Lifetime ES2056798T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863622221 DE3622221A1 (de) 1986-07-02 1986-07-02 Verfahren zur gentechnologischen gewinnung von proteinen unter verwendung gramnegativer wirtszellen

Publications (1)

Publication Number Publication Date
ES2056798T3 true ES2056798T3 (es) 1994-10-16

Family

ID=6304241

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87109492T Expired - Lifetime ES2056798T3 (es) 1986-07-02 1987-07-01 Procedimiento para la obtencion de proteinas por tecnologia genetica con utilizacion de celulas hospedantes gram-negativas.

Country Status (7)

Country Link
US (1) US5268270A (es)
EP (1) EP0254090B1 (es)
JP (1) JPH07100039B2 (es)
AT (1) ATE89318T1 (es)
DE (2) DE3622221A1 (es)
ES (1) ES2056798T3 (es)
WO (1) WO1988000238A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039415A1 (de) 1990-02-03 1991-08-08 Boehringer Mannheim Gmbh Verfahren zur herstellung rekombinanter proteine ohne n-terminalen methioninrest
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
DE4140699A1 (de) * 1991-01-11 1992-07-16 Boehringer Mannheim Gmbh Rekombinante iga-protease
US5965424A (en) * 1991-01-11 1999-10-12 Boehringer Mannheim Gmbh Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases
WO1996009395A2 (de) * 1994-09-21 1996-03-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Arzneimittel zur prophylaxe und behandlung von und diagnostika zur erkennung von autoimmunkrankheiten und viralen erkrankungen
GB9618960D0 (en) * 1996-09-11 1996-10-23 Medical Science Sys Inc Proteases
AU6211698A (en) * 1997-01-21 1998-08-07 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Iga1 protease fragment as carrier peptide
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
SI2255826T1 (sl) * 2002-08-02 2016-07-29 Glaxosmithkline Biologicals S.A. Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
SI1549338T1 (sl) * 2002-10-11 2011-04-29 Novartis Vaccines & Diagnostic Polipeptidna cepiva za ĺ iroko zaĺ äśito pred hipervirulentnimi miningokoknimi rodovi
EP2338987A1 (en) 2009-11-16 2011-06-29 ZYRUS Beteiligungsgesellschaft mbH & Co. Patente I KG Whole cell biocatalyst
EP2619306B1 (en) 2010-09-23 2015-05-20 Autodisplay Biotech GmbH Surface display of polypeptides containing a metal porphyrin or a flavin
WO2012152923A1 (en) 2011-05-12 2012-11-15 Autodisplay Biotech Gmbh Whole cell biocatalyst comprising a prenyltransferase
CN105164260B (zh) 2013-03-13 2019-05-31 自动显示生物技术有限公司 功能性蛋白在范围广泛的革兰氏阴性细菌中的改善的表面展示
WO2017186784A1 (en) 2016-04-26 2017-11-02 Autodisplay Biotech Gmbh Autodisplay of antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis

Also Published As

Publication number Publication date
JPH07100039B2 (ja) 1995-11-01
WO1988000238A1 (en) 1988-01-14
EP0254090A1 (de) 1988-01-27
ATE89318T1 (de) 1993-05-15
US5268270A (en) 1993-12-07
DE3785798D1 (de) 1993-06-17
EP0254090B1 (de) 1993-05-12
DE3622221A1 (de) 1988-01-14
JPH01500164A (ja) 1989-01-26

Similar Documents

Publication Publication Date Title
ES2056798T3 (es) Procedimiento para la obtencion de proteinas por tecnologia genetica con utilizacion de celulas hospedantes gram-negativas.
AU524856B2 (en) Method of making a selected protein
AU568067B2 (en) Oligonucleotide therapeutic agent and methods of making same
BR9904955A (pt) Dna bactéria pertencendo ao gênero escherichia, e, processo para produzir um aminoácido.
EP0375724A4 (en) Biologically active bactericidal/permeability-increasing protein fragments
NZ223312A (en) Precursor protein of amyloid plaque protein and dna encoding it
CA2122135A1 (en) Recombinant Core-Streptavidin
NO960839D0 (no) Bakterieeksporterte proteiner og acellulære vaksiner som er basert derpå
DE3750056T2 (de) Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
ES2007309A4 (es) Secrecion del factor de crecimiento insulinoide 1 en e.coli.
ATE143688T1 (de) Thermostabile (1,3-1,4)-beta-glucanase
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
GR3020993T3 (en) Novel process for the production of unfused protein in E. coli
GB8414354D0 (en) Purifying protein
KR970009340B1 (en) Mutant acidic fibroblast growth factor
EP0293079A3 (en) Chlamydia vaccine
AU3082795A (en) Hard and soft wheat thioredoxins h, homologous proteins, dna fragments coding for said proteins and methods for preparing same
DK610488A (da) Antikoagulatorisk protein pp4-x, dets fremstilling og anvendelse
DE3856392D1 (de) Klonierung von Malaria-spezifischen DNA-Sequenzen:Isolierung des Gens für das 140 kd Protein
DE68919619D1 (de) DNA-Sequenz, beteiligt an der Regulation der Expression einer DNA-Sequenz, die einen Polypeptid-Precursor kodiert, Expressionsvektoren und Methode der periplasmatischen Herstellung des Polypeptides.
AU5110390A (en) Cdna coding for placental protein 9 (pp9), the isolation and use thereof
SE8803567D0 (sv) Rekombinantisk, syntesen av maenniskofibroblast-beta1-interferon kodande plasmid-dnappr-ifnbeta-13, foerfarande foer konstruering av naemnda plasmid-dna och maennisko-beta1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika vl 903 (ppr-ifnbeta-13)
GB8823729D0 (en) Recombinant plasmid dna ppr-il2-19, coding for synthesis of human interleukin-2, method of bacteria escherichia coli vniigenetika vl 903 (ppr-il2-19) as producer of human interleukin-2, containing it

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254090

Country of ref document: ES